Are any of your clinical trials held back by slow recruitment?
The start for a successful clinical study is to efficiently recruit and retain the study population. But participant enrolment issues are a major reason for trial terminations. Global data analysis of all terminated trials within ClinTrials Database reported 55% of trials were terminated due to the low accrual rate.[1] Globally, it’s always stated than 80% of trials fail to enrol on time, resulting in an extension of study and or addition of new study sites: more sites or more time means the CRO gets more money.
Similarly, insufficient retention of the participants to study closeout is also an increasing issue as the remaining number of patients may be too small to meet the Primary Objective statistics.
Gaea Trial Acceleration works to solve patient recruitment issues with the site team at target sites. The process isn’t a silver bullet and is hard, smart, work based on years of experience. I visit top recruiters to see how they achieve enrollment – “best practice”- and visit with non- or slow enrolling sites to find out why they are not achieving. I solve what I can and take back to the sponsor to solve what I can’t– and follow up. I share relevant best practice with the sites.
I have an in-depth knowledge of clinical operations, from years in clinical operations as FSP and at Gaea CRO, and I understand the medical particularities of many target indications. I am persistent and can achieve acceleration of recruitment quite rapidly. Sooner is better as when they are dormant a longer time usually more than one visit is needed to get sites re-engaged.
Would you be open to discussing how we can help patient recruitment?
Pharmaceutical Technology Enrolment Issues are the Top Factor in Clinical Trial Terminations. 2018. Dec 05, [Last accessed on 2019 Dec 05]. Available from: https://wwwpharmaceutical-technologycom/comment/reasons-for-clincial-trial-termination.
